Swedberg K., Eneroth P., Kjekshus J., Wilhelmsen L.Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group . Circulation1990;82:1730-6.
2.
Francis GS, Benedict C., Johnstone DE et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation1990;82:1724-9.
3.
Anon.Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med1991;325:293-302.
4.
Anon.Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators . N Engl J Med1992;327:685-91.
5.
Rouleau JL, de Champlain J., Klein M. et al. Activation of neurohormonal systems in postinfarction left ventricular hypertrophy. J Am Coll Cardiol1993;22:390-8.
6.
St. John Sutton M., Pfeffer MA, Plappert T. et al., for the SAVE Investigators.Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril . Circulation1994;89:68-75.
7.
St. John Sutton M., Pfeffer MA, Moye L. et al., for the SAVE Investigators.Cardiovascular death and left ventricular remodelling two years after myocardial infarction. Baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial. Circulation1997 ;96:3294-9.
8.
Gaudron P., Eilles C., Kugler I., Ertl G.Progressive left ventricular dysfunction and remodelling after myocardial infarction. Potential mechanisms and early predictors. Circulation1993;87:755-63.
9.
Konstam MA, Rousseau MF, Kronenberg MWV et al., for the SOLVD Investigators.Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure . Circulation1992;86:431-8.
10.
Beltrami CA , Finato N., Rocco M. et al. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation1994;89:151-63.
11.
Cotran RS , Kumar V., Robbins SLRobbins' Pathologic Basis of Disease. 4th ed. Philadelphia : W B Saunders , 1989: 1519.
12.
Pfeffer MA, Braunwald E., Moyé LA et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med1992;327:669-77.
13.
Bottari SP, de Gasparo M., Steckelings UM, Levens NRAngiotensin II receptor subtypes: characterization, signalling mechanisms, and possible physiological implications. Front Neuroendocrinol1993;14:123-71.
14.
Timmermans PB, Wong PC, Chiu AT et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev1993 ;45:205-51.
15.
Rousseau-Plasse A., Lenfant M., Potier P.Catabolism of the hemoregulatory peptide N-Acetyl-Ser-Asp-Lys-Pro: a new insight into the physiological role of the angiotensin-I-converting enzyme N-active site. Bioorg Med Chem1996 ;4:1113-9.
16.
Esther CR Jr, Howard TE, Marino EM, Goddard JM, Capecchi MR, Bernstein KEMice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility. Lab Invest1996;74:953-65.
17.
Weber KT, Swamynathan SK, Guntaka RV, Sun Y.Angiotensin II and extracellular matrix homeostasis. Int J Biochem Cell Biol1999;31:395-403.
18.
Yamada H. , Fabris B., Allen AM, Jackson B., Johnston CI, Mendelsohn FaoLocalization of angiotensin converting enzyme in rat heart. Circ Res1991;68:141-9.
19.
Pinto JE , Viglione P., Saavedra JMAutoradiographic localization and quantification of rat heart angiotensin converting enzyme. Am J Hypertens1991;4:321-6.
20.
Sun Y. , Diaz-Arias AA, Weber KTAngiotensin-converting enzyme, bradykinin and angiotensin II receptor binding in rat skin, tendon and heart valves: an in vitro quantitative autoradiographic study. J Lab Clin Med1994;123:372-7.
21.
Sun Y. , Zhang JQ, Zhang J., Ramires FJAAngiotensin II, transforming growth factor-β1 and repair in the infarcted heart. J Mol Cell Cardiol1998;30:1559-69.
22.
Studer R. , Reinecke H., Müller B., Holtz J., Just H., Drexler H.Increased angiotensin-I converting enzyme gene expression in the failing human heart. Quantification by competitive RNA polymerase chain reaction. J Clin Invest1994;94:301-10.
23.
Sun Y. , Cleutjens JPM, Diaz-Arias AA, Weber KTCardiac angiotensin converting enzyme and myocardial fibrosis in the rat. Cardiovasc Res1994;28:1423-32.
24.
van Krimpen C., Schoemaker RG, Cleutjens JPM et al. Angiotensin I converting enzyme inhibitors and cardiac remodelling. Basic Res Cardiol1991;86(Suppl 1):S149-S155.
25.
Smits JFM , van Krimpen C., Schoemaker RG, Cleutjens JPM , Daemen MJAP.Angiotensin II receptor blockade after myocardial infarction in rats: effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content . J Cardiovasc Pharmacol1992;20:772-8.
26.
Volders PGA , Willems Iemg, Cleutjens JPM, Arends J-W., Havenith MG, Daemen MjapInterstitial collagen is increased in the non-infarcted human myocardium after myocardial infarction. J Mol Cell Cardiol1993;25:1317-23.
27.
Ratajska A. , Campbell SE, Sun Y., Weber KTAngiotenin II associated cardiac myocyte necrosis: role of adrenal catecholamines. Cardiovasc Res1994;28:684-90.
28.
Benjamin IJ , Jalil JE, Tan LB, Cho K., Weber KT, Clark WAIsoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ Res1989;65:657-70.
29.
Campbell SE , Janicki JS, Matsubara BB, Weber KTMyocardial fibrosis in the rat with mineralocorticoid excess: prevention of scarring by amiloride . Am J Hypertens1993;6:487-95.
30.
Darrow DC, Miller HCThe production of cardiac lesions by repeated injections of desoxycorticosterone acetate. J Clin Invest1942;21:601-11.
31.
Sun Y., Ratajska A., Zhou G., Weber KTAngiotensin converting enzyme and myocardial fibrosis in the rat receiving angiotensin II or aldosterone. J Lab Clin Med1993;122:395-403.
32.
Sun Y., Weber KTAngiotensin-converting enzyme and wound healing in diverse tissues of the rat. J Lab Clin Med1996;127:94-101.
33.
Weber KTFibrosis, a common pathway to organ failure: angiotensin II and tissue repair . Semin Nephrol1997;17:467-91.
34.
Katwa LC, RatajskaA,Cleutjens JPM et al. Angiotensin converting enzyme and kininase-II-like activities in cultured valvular interstitial cells of the rat heart. Cardiovasc Res1995 ;29:57-64.
35.
Filip DA, Radu A., Simionescu M.Interstitial cells of the heart valves possess characteristics similar to smooth muscle cells. Circ Res1986;59:310-20.
36.
Messier RH Jr, Bass BL, Aly HM et al. Dual structure and functional phenotypes of the porcine aortic valve interstitial population: characteristics of the leaflet myofibroblast. J Surg Res1994 ;57:1-21.
37.
Falkenhahn M., Franke F., Bohle RM et al. Cellular distribution of angiotensin-converting enzyme after myocardial infarction . Hypertension1995;25:219-26.
38.
Sun Y., Weber KTAngiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart. J Mol Cell Cardiol1996;28:851-8.
39.
Willems Iemg , Havenith MG, De Mey JGR, Daemen MjapThe α-smooth muscle actin-positive cells in healing human myocardial scars. Am J Pathol1994;145:868-75.
40.
Skalli O., Schürch W., Seemayer T. et al. Myofibroblasts from diverse pathologic settings are heterogeneous in their content of actin isoforms and intermediate filament proteins. Lab Invest1989;60:275-85.
41.
Sappino AP, Skalli O., Jackson B., Schurch W., Gabbiani G.Smooth-muscle differentiation in stromal cells of malignant and 0 non-malignant breast tissues. Int J Cancer1988;41:707-12.
42.
Desmoulière A., Redard M., Darby I., Gabbiani G.Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol1995;146:56-66.
43.
Sun Y.,Weber KTInfarct scar: a dynamic tissue. Cardiovasc Res2000;46:250-6.
44.
Sun Y.,Weber KTCells expressing angiotensin II receptors in fibrous tissue of rat heart. Cardiovasc Res1996;31:518-25.
45.
Weber KT, Sun Y., Katwa LC, Cleutjens JPM. Connective tissue : a metabolic entity?J Mol Cell Cardiol1995;27:107-20.
46.
Pradelles P. , Frobert Y., Créminon C., Ivonine H., Frindel E.Distribution of a negative regulator of haematopoietic stem cell proliferation (AcSDKP) and thymosin b4 in mouse tissues. FEBS Lett1991;289:171-5.
47.
Azizi M., Rousseau A., Ezan E. et al. Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline . J Clin Invest1996;97:839-44.
48.
Katwa LC,Tyagi SC, Campbell SE, Lee SJ, Cicila GT, Weber KTValvular interstitial cells express angiotensinogen, cathepsin D, and generate angiotensin peptides. Int J Biochem Cell Biol1996;28:807-21.
49.
Campbell SE , Katwa LCAngiotensin II stimulated expression of transforming growth factor-β1 in cardiac fibroblasts and myofibroblasts . JMol Cell Cardiol1997;29:1947-58.
50.
Willems Iemg , Havenith MG, Smits JFM, Daemen MJAP.Structural alterations in heart valves during left ventricular pressure overload in the rat. Lab Invest1994;71:127-33.
51.
Stoll M., Steckelings UM, Paul M., Bottari SP, Metzger R., Unger T.The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest1995;95:651-7.
52.
Nakajima M. , Hutchinson HG, Fuginaga M. et al. The angiotensin II type 2 (AT2) antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci USA1995;92:10663-7.
Katwa LC, Sun Y., Campbell SE et al. Pouch tissue and angiotensin peptide generation. J Mol Cell Cardiol1998;30:1401-13.
55.
Hokimoto S. , Yasue H., Fujimoto K., Sakata R., Miyamoto E.Increased angiotensin converting enzyme activity in left ventricular aneurysm of patients after myocardial infarction. Cardiovasc Res1995 ;29:664-9.
56.
Hirsch AT, Talsness CE, Schunkert H., Paul M., Dzau VJTissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res1991 ;69:475-82.
57.
Ou R., Sun Y., Ganjam VK, Weber KTIn situ production of angiotensin II by fibrosed rat pericardium. J Mol Cell Cardiol1996;28:1319-27.
58.
Sun Y., Ramires FJA, Zhou G., Ganjam VK,Weber KTFibrous tissue and angiotensin II. J Mol Cell Cardiol1997;29:2001-12.
59.
Weber KTExtracellular matrix remodelling in heart failure. A role for de novo angiotensin II generation. Circulation1997 ;96:4065-82.
60.
Cleutjens JPM , Verluyten MJA, Smits JFM, Daemen MJAP.Collagen remodeling after myocardial infarction in the rat heart. Am J Pathol1995;147:325-38.
61.
Gabbiani G. , Ryan GB, Majno G.Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction . Experientia1971;27:549-50.
62.
De Mey JGR , Fazzi GEA smooth muscle-like component in rat myocardial infarcts [abstract]. Hypertension1996;28:696.
63.
Desmoulière A. , Gabbiani G.The role of the myofibroblast in wound healing and fibrocontractive diseases. In: Clark RAF, ed. The Molecular and Cellular Biology of Wound Repair . 2nd ed. New York: Plenum Press, 1996:391-423.
64.
Kapanci Y., Assimacopoulos A., Irle C., Zwahlen A., Gabbiani G.`Contractile interstitial cells` in pulmonary alveolar septa: a possible regulator of ventilation-perfusion ratio? Ultrastructural, immunofluorescence, and in vitro studies. J Cell Biol1974;60:375-92.
65.
HenneyAM,Parker DJ , Davies MJCollagen biosynthesis in normal and abnormal human heart valves. Cardiovasc Res1982;16:624-30.
66.
Majno G., Gabbiani G., Hirschel BJ, Ryan GB, Statkov PRContraction of granulation tissue in vitro: similarity to smooth muscle . Science1971;173:548-50.
67.
Zhang G., Moorhead PJ, el Nahas AMMyofibroblasts and the progression of experimental glomerulonephritis . Exp Nephrol1995;3:308-18.
68.
Goumenos DS , Brown CB, Shortland J., El Nahas AMMyofibroblasts, predictors of progression of mesangial IgA nephropathy . Nephrol Dial Transplant1994;9:1418-25.
69.
Roberts ISD , Burrows C., Shanks JH, Venning M., McWilliam LJInterstitial myofibroblasts: predictors of progression in membranous nephropathy . J Clin Pathol1997;50:123-7.
70.
Weber KT , Brilla CGPathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation1991;83:1849-65.
71.
Nicoletti A. , Michel J.-B. Cardiac fibrosis and inflammation: interaction with hemodynamic and hormonal factors. Cardiovasc Res1999;41:532-43.
72.
Robert V. , Heymes C., Silvestre J-S., Sabri A., Swynghedauw B., Delcayre C.Angiotensin AT1 receptor subtype as a cardiac target of aldosterone. Role in aldosterone-salt-induced fibrosis. Hypertension1999;33:981-6.
73.
Jugdutt BI , Khan MI, Jugdutt SJ, Blinston GEEffect of enalapril on ventricular remodelling and function during healing after anterior myocardial infarction in the dog . Circulation1995 ;91:802-12.
74.
Jugdutt BI, Schwarz-Michorowski BL, Khan MIEffect of long-term captopril therapy on left ventricular remodelling and function during healing of canine myocardial infarction. J Am Coll Cardiol1992;19:713-21.
75.
Jugdutt BIEffect of captopril and enalapril on left ventricular geometry, function and collagen during healing after anterior and inferior myocardial infarction in a dog model. J Am Coll Cardiol1995;25:1718-25.
76.
Michel J.-B, Lattion A-L., Salzmann J-L. et al. Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ Res1988 ;62:641-50.
77.
van Krimpen C., Smits JFM, Cleutjens JPM et al. DNA synthesis in the non-infarcted cardiac interstitium after left coronary artery ligation in the rat heart: effects of captopril. J Mol Cell Cardiol1991 ;23:1245-53.
78.
Bélichard P. , Savard P., Cardinal R. et al. Markedly different effects on ventricular remodelling result in a decrease in inducibility of ventricular arrhythmias . J Am Coll Cardiol1994;23:505-13.
79.
Litwin SE, Litwin CM, Raya TE, Warner AL, Goldman S.Contractility and stiffness of non-infarcted myocardium after coronary ligation in rats. Effects of chronic angiotensin converting enzyme inhibition . Circulation1991;83:1028-37.
80.
Wollert KC, Studer R., Doerfer K. et al. Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat. Circulation1997;95:1910-17.
81.
Frimm C de C., Sun Y., Weber KTAngiotensin II receptor blockade and myocardial fibrosis of the infarcted rat heart. J Lab Clin Med1997;129:439-46.
82.
Yamagishi H. , Kim S., Nishikimi T., Takeuchi K., Takeda T.Contribution of cardiac renin-angiotensin system to ventricular remodelling in myocardial-infarcted rats. J Mol Cell Cardiol1993;25:1369-80.
83.
Schieffer B. , Wirger A., Meybrunn M. et al. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodelling after myocardial infarction in the rat. Circulation1994;89:2273-82.
84.
Sun Y.,Weber KTAngiotensin II receptor binding following myocardial infarction in the rat . Cardiovasc Res1994;28:1623-8.
85.
Pimentel JL Jr, Sundell CL, Wang S., Kopp JB, Montero A., Martínez-Maldonado M.Role of angiotensin II in the expression and regulation of transforming growth factor-β in obstructive nephropathy. Kidney Int1995;48:1233-46.
86.
Morrissey JJ , Ishidoya S., McCracken R., Klahr S.The effect of ACE inhibitors on the expression of matrix genes and the role of p53 and p21 (WAF1) in experimental renal fibrosis . Kidney Int1996;49(Suppl 54):S83-S87.
87.
Ishidoya S. , Morrissey J., McCracken R., Reyes A., Klahr S.Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction . Kidney Int1995;47:1285-94.
88.
Kaneto H., Morrissey J., McCracken R., Reyes A., Klahr S.Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney. Kidney Int1994 ;45:1637-47.
89.
Pimentel JL Jr, Martinez-Maldonado M., Wilcox JN, Wang S., Luo C.Regulation of renin-angiotensin system in unilateral ureteral obstruction. Kidney Int1993;44:390-400.
90.
Ishidoya S. , Morrissey J., McCracken R., Klahr S.Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy. Kidney Int1996;49:1110-19.
91.
Yanagisawa H., Morrissey J., Morrison AR, Klahr S.Eicosanoid production by isolated glomeruli of rats with unilateral ureteral obstruction. Kidney Int1990;37:1528-35.
92.
Diamond JR, Anderson S.Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis. Am J Pathol1990;137:1323-32.
93.
Lafayette RA , Mayer G., Meyer TWThe effects of blood pressure reduction on cyclosporine nephrotoxicity in the rat. J Am Soc Nephrol1993;3:1892-9.
94.
Cohen EP, Moulder JE, Fish BL, Hill P.Prophylaxis of experimental bone marrow transplant nephropathy. J Lab Clin Med1994;124:371-80.
95.
Burdmann EA , Andoh TF, Nast CC et al. Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril .AmJPhysiol1995;269:F491-F499.
96.
Tanaka R., Sugihara K., Tatematsu A., Fogo A.Internephron heterogeneity of growth factors and sclerosis--modulation of platelet-derived growth factor by angiotensin II. Kidney Int1995;47:131-9.
97.
Ikoma M., Kawamura T., Kakinuma Y., Fogo A., Ichikawa I.Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions. Kidney Int1991;40:195-202.
98.
Shibouta Y. , Chatani F., Ishimura Y. et al. TCV-116 inhibits renal interstitial and glomerular injury in glomerulosclerotic rats . Kidney Int1996;49(Suppl 55):S115-S118.
99.
Anderson S. , Rennke HG, Brenner BMTherapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest1986 ;77:1993-2000.
100.
Juncos LI, Carrasco Dueñas S., Cornejo JC, Broglia CA, Cejas H.Long-term enalapril and hydrochlorothiazide in radiation nephritis . Nephron1993;64:249-55.
101.
Nakamura T. , Honma H., Ikeda Y. et al. Renal protective effects of angiotensin II receptor I antagonist CV-11974 in spontaneously hypertensive stroke-prone rats (SHR-sp). Blood Press1994;3(Suppl 5):S61-S66.
102.
Nakamura T. , Obata J., Kuroyanagi R. et al. Involvement of angiotensin II in glomerulosclerosis of stroke-prone spontaneously hypertensive rats.Kidney Int1996;49(Suppl 55):S109-S112.
103.
Kim S. , Ohta K., Hamaguchi A. et al. Contribution of renal angiotensin II type I receptor to gene expressions in hypertension-induced renal injury . Kidney Int1994;46:1346-58.
104.
Kim S. , Ohta K., Hamaguchi A. et al. Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-β1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats . J Pharmacol Exp Ther1995;273:509-15.
105.
Ward WF, Molteni A.,Ts'ao C.Radiation-induced endothelial dysfunction and fibrosis in rat lung: modification by the angiotensin converting enzyme inhibitor CL242817. Radiat Res1989;117:342-50.
106.
Ward WF, Molteni A., Ts'ao C., Kim YT, Hinz JMRadiation pneumotoxicity in rats: modification by inhibitors of angiotensin converting enzyme. Int J Radiat Oncol Biol Phys1992;22:623-5.
107.
Ward WF, Molteni A.,Ts'ao C.-H, Hinz JMCaptopril reduces collagen and mast cell accumulation in irradiated rat lung . Int J Radiat Oncol Biol Phys1990 ;19:1405-9.
108.
Molteni A. , Ward WF, Ts'ao C., Soliday NH, Dunnes M.Monocrotaline-induced pulmonary fibrosis in rats: amelioration by captopril and penicillamine. Proc Soc Exp Biol Med1985;180:112-20.
